Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05030467 · ClinicalTrials.gov registry record · NA
Leveraging Electronic Health Record (EHR) Tools to Reduce Health Disparities for Patients With Uncontrolled Hypertension
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 49,210
- Enrollment target
NCT05030467: Completed NA study, sponsored by Brigham and Women's Hospital.
NCT05030467 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 49,210 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (3407% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05030467, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 49,210 participants
- Enrollment target
Study Summary
A two-arm cluster randomized controlled trial targeting primary care providers will be conducted to evaluate the impact of a multicomponent electronic health record (EHR) intervention on hypertension management. Given the cluster trial design, randomization will be conducted at the site level, and in the intervention sites, all eligible providers will receive the intervention. The intervention consists of enhancing tools already available to primary care providers in the EHR system, including developing and implementing provider disparities dashboards, enhancing electronic decision support, and simplifying self-monitoring orders and communication materials. The intervention aims to improve blood pressure control and reduce health disparities in racial and ethnic minorities. Findings from this trial will provide important insight into whether a multicomponent intervention targeting providers and leveraging health information technology can reduce health disparities.
Primary Outcome
Change in systolic blood pressure from identification to the end of the 12-month follow-up, using values in the EHR from ambulatory care encounters
Interventions
- BEHAVIORAL REDUCE-BP Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49,210 participants |
| Start Date | 2022-05-03 |
| Est. Completion | 2024-06-01 |
| Phase | NA |
What the finished NCT05030467 record still lists
NCT05030467 is an interventional study that assigns participants to a tested intervention. Its 49,210 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (3407% higher).
The record links to 0 conditions, and to 1 intervention - of which REDUCE-BP Intervention is the first listed.
NCT05030467 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05030467 about?
NCT05030467 is a clinical study titled "Leveraging Electronic Health Record (EHR) Tools to Reduce Health Disparities for Patients With Uncontrolled Hypertension". A two-arm cluster randomized controlled trial targeting primary care providers will be conducted to evaluate the impact of a multicomponent electronic health record (EHR) intervention on hypertension management. Given the cluster trial design, randomization will be conducted at the site level, and i...
What is the current status of trial NCT05030467?
This trial is currently completed. It is a NA study. The enrollment target is 49,210 participants. The study started on 2022-05-03. Estimated completion is 2024-06-01.
What interventions are being tested in trial NCT05030467?
The interventions under investigation include: REDUCE-BP Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05030467?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05030467's enrollment target sits among peer trials
49,210 7th of 2000 higher than 1,994 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00500123 · 50,000 participants
The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
- NCT01885299 · 50,000 participants
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
- NCT03452774 · 50,000 participants
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- NCT04629586 · 50,000 participants
The T1D Exchange Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI